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Next-generation RNA sequencing of FFPE subsections reveals
highly conserved stromal reprogramming between canine
and human mammary carcinoma
Parisa Amini1,*, Sina Nassiri2,*, Julia Ettlin1, Alexandra Malbon3 and Enni Markkanen1,‡
ABSTRACT
Spontaneous canine simple mammary carcinomas (mCA) are often
viewed as models of human mCA. Cancer-associated stroma (CAS)
is central for initiation and progression of human cancer, and is likely
to play a key role in canine tumours as well. However, canine CAS
lacks characterisation and it remains unclear how canine and human
CAS compare. Formalin-fixed paraffin embedded (FFPE) tissue
constitutes a valuable resource of patient material, but chemical
crosslinking has largely precluded its analysis by next-generation
RNA sequencing (RNAseq). We have recently established a protocol
to isolate CAS and normal stroma from archival FFPE tumours using
laser-capture microdissection followed by RNAseq. Using this
approach, we have analysed stroma from 15 canine mCA. Our data
reveal strong reprogramming of canine CAS. We demonstrate a high-
grade molecular homology between canine and human CAS, and
show that enrichment of upregulated canine CAS genes strongly
correlates with the enrichment of an independently derived human
stromal signature in the TCGA breast tumour dataset. Relationships
between different gene signatures observed in human breast cancer
are largely maintained in the canine model, suggesting a close
interspecies similarity in the network of cancer signalling circuitries.
Finally, we establish the prognostic potential of the canine CAS
signature in human samples, emphasising the relevance of studying
canine CAS as a model of the human disease. In conclusion, we
provide a proof-of-principle to analyse specific subsections of FFPE
tissue by RNAseq, and compare stromal gene expression between
human and canine mCA to reveal molecular drivers in CAS
supporting tumour growth and malignancy.
KEY WORDS: Formalin-fixed paraffin embedded, RNAseq, Laser-
capture microdissection, Canine mammary carcinoma, Breast
cancer, Tumour stroma
INTRODUCTION
The microenvironment surrounding cancer cells is pivotal for growth
and survival of many different tumours (Hanahan and Coussens,
2012). This so-called cancer-associated stroma (CAS), consisting of a
mixture of different non-tumour cells such as immune cells,
fibroblasts and others, as well as extracellular matrix, plays a key
role in cancer initiation and progression (Hanahan and Coussens,
2012). The role of CAS in tumour biology has been widely
documented (Bissell and Hines, 2011). CAS directly promotes the
growth of tumour cells by secreting and/or activating molecules such
as growth factors, nutrients and cytokines, among others (e.g.
reviewed by Bissell and Hines, 2011; Hanahan and Coussens, 2012).
Still, the mechanisms underlying the formation of CAS and the
molecular dialogue between CAS and cancer cells remain poorly
understood.
Based on the closely related pathophysiology, spontaneously
occurring cancer in the domestic dog is increasingly viewed as a
valuable model to foster understanding of cancer biology and
potentially identify novel therapeutic targets in both dogs and
human patients (Gardner et al., 2015; Karlsson and Lindblad-Toh,
2008; Rogers, 2015). In particular, owing to strong molecular and
clinical similarities, canine mammary carcinoma (mCA) are
regarded as excellent models for human mCA and are thought to
overcome several of the limitations of xenograft or genetically
modified rodent tumour models (Liu et al., 2014; Queiroga et al.,
2011b; Schiffman and Breen, 2015). Histologically and at the
molecular level, canine simple mCA closely replicate the biology of
human mCA and mirror many of the genomic aberrations found
therein, and are thus thought to reflect human mCA (Liu et al., 2014;
Queiroga et al., 2011b). Also, as the most frequently occurring
cancer in intact female dogs, canine mCA are highly relevant in the
veterinary clinical setting (Salas et al., 2015). Canine simple mCA
are classified as malignant epithelial neoplasms that infiltrate the
surrounding mammary tissue, thus inducing a strong stromal
response and myofibroblast proliferation, and can give rise to
metastases (Goldschmidt et al., 2011).
Given the central role of CAS in the biology of human cancer in
general, and mCA in particular, it is likely to also play a central role
in the growth and development of canine mCA. Until now, however,
despite the fact that canine cancer is increasingly analysed, canine
CAS almost entirely lacks characterisation. Thus, it remains unclear
whether CAS has a similar role in canine cancers, which
mechanisms are involved in its formation and whether CAS from
dogs is comparable to human CAS. Understanding the role of CAS
in canine cancers and its comparability to human CAS is pivotal to
define the validity of canine cancers as models for the human
disease. Furthermore, a comparison of human and canine CAS can
not only reveal key changes that are of central importance for the
development of the disease itself, but also lead to identification of
novel targets for pharmacological intervention against cancer.
Formalin-fixed paraffin embedded (FFPE) tissue constitutes a vast
resource of patientmaterial. However, FFPE heavily impacts onRNAReceived 6 May 2019; Accepted 9 July 2019
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quantity and quality, which proves challenging in downstream
applications. To enable the use of this valuable tissue resource and
analysis of CAS reprogramming in tumours, we have established
isolation of CAS and matched normal stroma from canine simple
mCA by laser-capture microdissection (LCM) from archival FFPE
samples followed by analysis by next-generation RNA sequencing
(RNAseq). Here, we provide the proof-of-principle for this novel
protocol by analysing CAS and matched normal stroma isolated by
LCM from FFPE tissue from 15 clinical cases of canine simplemCA.
RESULTS
RNAseq-based transcriptomic profiling of matched cancer-
associated and normal stroma from canine mCA isolated
by LCM from FFPE specimens
To analyse CAS from canine simple mCA, we concurrently isolated
RNA from CAS and matched ‘normal’ stroma (i.e. stroma adjacent
to unaltered mammary glands) from clinical FFPE specimens using
LCM, and subjected these samples to RNAseq using our recently
established protocol (Amini et al., 2017). Representative images for
tissue isolation and patient characteristics for all cases included
in the study can be found in Table 1 and Fig. S1. Remarkably,
principal component analysis (PCA) revealed clear separation
between CAS and normal stroma, highlighting the distinction
between CAS and normal stroma as the major source of variability
in the data (Fig. 1A). Differential expression analysis with a false
discovery rate (FDR) cut-off of 0.01 and fold change threshold of 2
revealed 884 genes to be significantly deregulated in CAS compared
to normal stroma, with 446 genes significantly upregulated and 438
genes significantly downregulated in CAS (Fig. 1B and Table S1).
Over-representation analysis of Gene Ontology (GO) terms
associated with biological processes, cellular components and
molecular functions for up- and downregulated genes suggested the
strongest changes in the following categories: immune system
process, biological adhesion, cell differentiation, proliferation,
growth, extra cellular matrix and collagen organisation (Fig. 1C-H).
Association of significantly deregulated genes with the top over-
represented GO terms revealed downregulated genes to participate in
angiogenesis and upregulated genes to play a role in ‘cellular
response to organic substance’, which is related to any process that
results in a change in state or activity of a cell (in terms of movement,
secretion, enzyme production, gene expression, etc.) as a result of an
organic substance stimulus (Fig. S2). To validate the RNAseq data,
we measured gene expression of six significantly differentially
expressed genes (HMCN2, CLEC4G, VIT, COL11A1, SFRP2 and
TFPI2) by RT-qPCR. All of the tested genes showed significant
expression changes consistent with the RNA-seq data (Fig. 2A-G). In
addition, we validated differential expression in CAS versus normal
stroma of three genes [upregulation of α-smooth muscle actin (α-
SMA, encoded by ACTA2), upregulation of collagen 4α1 (COL4A1)
and downregulation of vimentin in CAS compared to normal stroma]
on protein level using immunofluorescence (Fig. 2H-K).
To enumerate the cellular landscape of tumour and normal stroma
in canine mCA, we used xCell, a state-of-the-art algorithm that
performs cell-type enrichment analysis from gene expression data
for 64 immune and stroma cell types (Aran et al., 2017). As most
deconvolution algorithms (including xCell) rely on human (and
seldom mouse) gene signatures, we used the human orthologues of
canine genes to perform in silico deconvolution. Fig. S3 shows
differentially abundant cell types in CAS and normal stroma based
on xCell enrichment scores. Unsupervised clustering of samples
based on xCell enrichment scores revealed a clear separation
between CAS and normal stroma, further corroborating our finding
at the gene expression level. Taken together, these findings support
the validity of our approach to analyse FFPE tissue subsections
through LCM coupled with RNAseq, and demonstrate strong
reprogramming to occur in CAS from canine mCA.
CAS from canine and human mCA display a high grade
of molecular homology
To gain insight into whether and to what degree CAS of canine and
human mCA are comparable, we compared our dataset with a
similar published human breast cancer patient dataset (GSE35019)
consisting of matched stromal samples of invasive ductal carcinoma
(IDC), ductal carcinoma in situ (DCIS) and normal stroma (Vargas
et al., 2012). We postulated that if canine and human mCA were to
share a high level of molecular homology, differentially regulated
genes in canine CAS versus normal stroma should exhibit a similar
expression pattern in the human dataset. To test this hypothesis, we
ranked all genes in the human dataset based on fold change
expression in IDC stroma versus normal stroma. We then assessed
the enrichment of canine-derived CAS signature in this ranked gene
list. Remarkably, we found the upregulated subset of the canine
CAS signature to be enriched on the left-hand side of the ranked
gene list (P-value <0.001), demonstrating overexpression in IDC
Table 1. Overview of canine simple mCA cases included in this study
Case # Gender Breed
Age
(years)
Subtype of simple
carcinoma
Age of sample
(months)
1 F Basset 12 Tubular 3
2 F Vizsla 10 Cystic-papillary 18
3 F Samoyed 5 Tubulo-papillary 7
4 F Maltese 14 Tubular 3
5 F Tibetan Terrier 12 Tubular 15
6 F/N West Highland White Terrier 12 Tubular-solid 13
7 F Havanese 13 Tubular 11
8 F Chihuahua 8 Tubulo-papillary 7
9 F/N Bracke 9 Cribriform 14
10 F/N N.D. 13 Tubular 7
11 F/N Appenzell Mountain Dog 6 Tubular 18
12 F Boxer 9 Tubulo-papillary 8
13 F N.D. 4 Cystic-papillary 23
14 F/N Beagle 13 Tubular 27
15 F/N Chihuahua 10 Tubular 13
Clinical data from dogs with simple mCA; Case #, case number as referred to within this study; F/N, female, neutered; N.D., not disclosed; age, age at excision of
tumour; age of sample, time between initial tumour excision and sampling of stroma/RNA extraction.
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stroma (Fig. 3A, showing the top 100 up- and downregulated genes
from the canine CAS signature in the ranked human gene list, and
Fig. S4 for all genes). In contrast, the downregulated subset of the
canine CAS signature was enriched on the right-hand side (P-value
<0.001), which is associated with normal stroma. Similar results
were obtained using an alternative gene set testing procedure
(Fig. 3B). As a complementary approach to interrogate the
molecular homology between canine and human mCA, we used a
well-established and manually curated set of stromal genes obtained
using human samples (Yoshihara et al., 2013) and computed the
stromal enrichment scores using single sample Gene Set
Enrichment Analysis (ssGSEA) (Vargas et al., 2012), an
extension of the popular GSEA method that calculates the extent
at which members of a given gene set are co-ordinately up- or
downregulated within individual samples. Using this approach, we
found the enrichment of the canine-derived stromal signature to be
highly positively correlated (Spearman rho=0.72, P-value <0.001)
with the enrichment of the human-derived stromal signature in the
breast cancer subset of TCGA (sample size >1000), further
supporting the presence of strong molecular homology in CAS
between the two species (Fig. 3C). To further explore the molecular
similarities between canine and human mCA, we sought to identify
perturbations in signalling pathways present in CAS of both species.
Enrichment analysis of hallmark pathways showed a substantial
number of pathways to be significantly deregulated in the same
direction in both human and canine CAS (Fig. 3D). The commonly
perturbed pathways include angiogenesis, epithelial mesenchymal
translation, glycolysis, allograft rejection, interferon gamma and
alpha response, complement, estrogen response late and early,
adipogenesis, fatty acid metabolism, E2F targets, G2M checkpoint,
MYC targets, mitotic spindle, unfold protein response, myogenesis
and mTORc pathway. GSEA leading edge subsets of genes deriving
the conserved perturbations observed in both species are detailed in
Table 2. To sum up, these results clearly demonstrate the presence of
significant molecular homology between CAS in canine mCA and
CAS from human breast cancers.
The human orthologues of the canine-derived CAS signature
are enriched among highly prognostic genes in human mCA
The tumour stroma has important roles in development, progression
and metastasis of different tumour types, and targeting both cancer
cells and the stromal compartment is thought to increase efficiency
Fig. 1. RNAseq-based transcriptomic analysis of CAS and matched normal stroma from 15 canine simple mCA. (A) PCA of CAS and normal stroma samples
isolated from canine simple mCA. PCA was performed using all genes. (B) Volcano plot highlighting differentially expressed genes in CAS compared to normal
stroma, using fold change >2 and FDR <0.01 as cut-off values. (C-E) Top 10 over-representedGO terms associated with biological processes (C), cellular components
(D) and molecular functions (E) among genes significantly upregulated in CAS compared to normal stroma. (F-H) Top 10 over-represented GO terms associated with
biological processes (F), cellular components (G) and molecular functions (H) among genes significantly downregulated in CAS compared to normal stroma.
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of anticancer therapy and improve patient survival (Valkenburg
et al., 2018). Given the scarcity of long-term survival data from the
canine cases included in this analysis, we set out to explore the
clinical relevance of our canine-derived CAS signature by exploring
the association with survival of their human orthologues using the
PRECOG database (Gentles et al., 2015). PRECOG enables
querying the association between expression of a given gene and
patient survival using aggregate data from multiple studies via
survival meta z-scores. We hypothesised that high levels of
molecular homology between canine and human mCA should
manifest in a prognostic value of the canine CAS signature.
Reassuringly, we found that upregulated genes in canine CAS were
highly enriched among adversely prognostic genes (pre-ranked
GSEA P-value <0.001), whereas upregulated genes in normal
stroma were highly enriched among favourably prognostic genes
(pre-ranked GSEA P-value <0.001). Fig. 4A shows the full list of
genes, and Fig. 4B displays the top 20 genes from the canine CAS
signature, with the largest meta z-scores indicating the strongest
association with survival (for the full list of genes see Table S2).
Note that the positive and negative meta z-scores as described in
Gentles et al. (2015) indicate adversely and favourably prognostic
genes, respectively. In conclusion, our findings suggest that the
molecular homology between CAS from human and canine mCA is
strongly rooted in conservation of key signalling pathways that
underlie the prognostic value of CAS-derived gene expression
changes in both species, thus further emphasising the merit of
canine mCA as a model for human mCA.
DISCUSSION
Archival FFPE tissue samples constitute a vast and very valuable
collection of patient samples for biomedical research. However,
owing to chemical cross-linking of macromolecules, extraction of
RNA from these tissues is challenging in terms of quantitative and
qualitative constraints, which heavily impact on downstream
analysis. Despite these drawbacks, several studies have proven
that it is feasible to analyse RNA or miRNA from FFPE with
Fig. 2. Immunohistochemistry and RT-qPCR validation of selected genes from the carcinoma dataset. (A-F) Relative mRNA levels of CAS-associated
genes in normal stroma and CAS isolated by LCM, measured using RT-qPCR:HMCN2 (A);CLEC4G (B); VIT (C);COL11A1 (D); SFRP2 (E); TFPI2 (F). Data are
mean±s.e.m., normalised to expression levels in normal stroma (forHMCN2,CLEC4G andVIT), or CAS (COL11A1,SFRP2, TFPI2), respectively.P-values were
calculated using student’s t-test, and significance cutoff was set at P=0.05. (G) Summary of the expression trends as detected by RT-qPCR and RNAseq.
(H-J) Immunofluorescent staining of α-SMA (red, H), collagen IV (green, I) and vimentin (purple, J) in CAS and normal stroma of a representative canine simple
mCA sample. DAPI staining (blue) visualises cell nuclei, and marks large densely blue areas in the left panels as tumour cells, while demarcating normal
mammary glands in the panels on the right. (K) Summary of the expression trends as detected by RNAseq or immunofluorescence. Scale bars: 200 μm.
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RNAseq, and that results from FFPE are largely consistent with
fresh-frozen material (e.g. Hedegaard et al., 2014; Meng et al.,
2013; Sinicropi et al., 2012). However, all of these studies relied on
rather large amounts of input tissue (3-6 full-size sections of 10 μm
thickness, or 5-10 mg tissue) and between 100-500 ng of RNA.
When, as an additional constraint, sample size is limiting, such as
when performing laser-capture microdissection (LCM) to isolate
specific subpopulations of cells, recovery of sufficient RNA for
RNAseq-based analysis pipelines becomes virtually impossible,
effectively precluding RNAseq-based approaches of small FFPE
samples. To enable utilisation of valuable archival FFPE tissue
samples and to be able to analyse CAS reprogramming in canine
mCA, we have recently established a protocol for RNA extraction
from LCM-FFPE tissue to be amenable to analysis by RNA-seq
(Amini et al., 2017). Using this novel protocol, which routinely uses
only 4 ng of input RNA, we have now analysed CAS and matched
normal stroma isolated by LCM from FFPE tissue from 15 clinical
cases of canine simple mCA. Importantly, this approach is not
limited to isolation of CAS, but can be leveraged to analyse almost
any subsection of interest from FFPE tissues. Naturally, the protocol
can also be applied to entire sections of FFPE material that have not
undergone microdissection. Historically, LCM-based interrogation
of human CAS and other tissue subsections has been performed
mainly through analysis of fresh-frozen tissue sections (Erickson
et al., 2009). Although feasible, procurement of fresh-frozen tissue
sections of a given pathology necessitates a high grade of
coordination between treating physicians and researchers, and can
usually only be performed in prospective settings, as fresh freezing
of tissue is not normally integrated into the diagnostic standard
workflow. Also, storage and handling of fresh-frozen tissue is more
Fig. 3. CAS from canine and human mCA display a high grade of molecular homology. (A) Competitive gene set testing to compare canine CAS to human
CAS. GSEA-like running sum statistic depicting the location of selected genes on a ranked list of genes in human IDC stroma compared to normal stroma
(GSE35019). Top 100 upregulated genes identified in canine tumour stroma are indicated as red vertical bars, top 100 downregulated genes identified in canine
tumour stroma are indicated as blue vertical bars. (B) Self-contained gene set testing (QuSAGE method) to assess the average differential expression of canine-
derived gene sets (i.e. up- and downregulated genes in canine CAS: 449 up- and 425 downregulated genes) in human breast cancer stroma. The x-axis
demonstrates mean fold change expression in CAS compared to normal stroma in human mCA (GSE35019). The y-axis indicates the distribution of fold change
expression within each set. P-values were calculated by comparing mean fold change to fold change of 1 using Welch’s t-test. (C) Positive correlation
(Spearman’s rho=0.72) between the enrichment of significantly upregulated genes derived from canine data and the enrichment of an independently derived
human stromal signature (ESTIMATE stromal signature; Yoshihara et al., 2013) in the breast cancer dataset from TCGA including >1000 cases. (D) GSEA
analysis of hallmark pathways (MSigDB) in human data (GSE35019, top row) and canine data (bottom row). Red indicates pathways that were deemed significant
(FDR<0.1) in both datasets and showed enrichment in CAS compared to normal stroma. Blue indicates pathways that were deemed significant (FDR<0.1) in both
datasets and showed enrichment in normal stroma compared to CAS.
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cost- and labour-intensive than that of standard FFPE blocks. In
addition, standard diagnostic routine workflows strongly depend on
FFPE tissue, because of good tissue morphology and ease of
handling, which results in production of large amounts of FFPE
tissue specimens in pathology departments that can be stored almost
indefinitely at room temperature.
CAS plays a key role in cancer initiation and progression in human
cancer (Bissell and Hines, 2011; Hanahan and Coussens, 2012), and
thus it likely occupies a central role in the biology of canine tumours as
well. Spontaneous canine mCA are often regarded as valuable models
for humanmCA, but the lack of data on canineCAS and thus unbiased
cross-species analysis of molecular homologies and differences
undermine the validity of these assumptions. To date, however,
CAS in canine cancers in general, and canine mCA in particular,
entirely lacks systematic characterisation. We have recently analysed
the expression of a small panel of genes known to be deregulated in
human CAS by qRT-PCR in CAS from canine simple mCA (Ettlin
et al., 2017). These initial results suggested strong overlaps in CAS-
related biology between canine and human mCA. Here, we provide
the first dataset for CAS and matched normal stroma in canine
mCA obtained through systematic RNAseq-driven transcriptomic
characterisation (Figs 1,2). Our results reveal strong reprogramming in
CAS from canine mCA. These results will serve as a basis for further
mechanistic follow-up studies of the involvement of stromal genes in
development and progression of canine mCA, and have the potential
to reveal novel prognostic markers and therapeutic targets.
Our unbiased approach has yielded highly interesting insights into
the degree of cross-species homology of CAS reprogramming
between human and canine mCA. We demonstrate that
reprogramming of CAS from human and canine mCA is highly
comparable, and relationships between different gene signatures
observed in human breast cancer are largely maintained in the canine
model, suggesting a close interspecies similarity in the network of
cancer signalling circuitries (Fig. 3). As an example, in the context of
angiogenesis, we found that vascular endothelial growth factor A
(VEGFA), secreted phosphoprotein 1/osteopontin (SPP1), periostin
(osteoblast specific factor; POSTN) and VAV guanine nucleotide
exchange factor (VAV2) are important commonly regulated genes
between human and canine CAS. All of these are known to enhance
tumour progression in cancer in general, and mCA in particular
(Hunter et al., 2006; Morishita, 2011; Queiroga et al., 2011a; Wang
and Ouyang, 2012). Various studies investigating spontaneous mCA
of both canine and human origin support the role of the epithelial-to-
mesenchymal transition (EMT) in metastasis in both species
(Lamouille et al., 2014; Raposo-Ferreira et al., 2018; Thiery,
2002). Indeed, cells in CAS have been shown to be potent
inducers of EMT (Jing et al., 2011). Furthermore, the collagen-
associated genes COL11A1, COL4A1/2 and ADAM12, which we
identified as commonly regulated between both species, are known to
play an important role in EMT. COL11A1 mRNA is significantly
increased in various types of cancers (Raglow and Thomas, 2015),
and its overexpression in CAS is associated with poor prognosis in
human mCA (Parl et al., 1984). Expression of type IV collagen is
related to tumour malignancy and fibroblast infiltration (Chen et al.,
2015). Indeed, the levels of type IV collagen protein were strongly
increased in CAS from canine mCA (Fig. 2H,K). Among the
common glycolytic genes, PLOD1/2 and FUT8 are among the most
important deregulated targets. Activation of PLOD1 and PLOD2 at
the transcription level by HIF-1 is required for biogenesis of collagen
in breast cancer cells (Gilkes et al., 2013). By remodelling the TGF-β
receptor core fucosylation, FUT8 expression influences breast cancer
invasiveness (Tu et al., 2017). Immune-related pathways
Table 2. Leading edge summary for hallmark gene sets that are consistently perturbed between canine and human mCA
Hallmark pathway Common genes between canine and human CAS
MTORC1 signalling EEF1E1, CCNF, SYTL2, MTHFD2, PLOD2, ITGB2, TFRC, CXCR4, TRIB3, HMBS, PIK3R3, TOMM40, SLA, SHMT2, EPRS,
PSMC4, CCNG1, CORO1A, HSP90B1, TUBG1, CCT6A, TPI1, G6PD, P4HA1, SSR1, M6PR, ATP6V1D, YKT6, FADS2,
SLC1A4, GAPDH, CDC25A, RRM2
Myc targets CDC20, CCNA2, TYMS, KPNA2, CCT5, SNRPD1, ILF2, HPRT1, PABPC4, RFC4, PRDX4, IARS, DHX15, GLO1, EPRS,
PSMC4, HDAC2, RPL6, VBP1, NOLC1, PSMB2, SRPK1, XPOT, YWHAQ, COPS5, DUT, RPL18, SRM, HDGF, PSMB3,
PSMD1, RNPS1, RUVBL2, SNRPD2, RANBP1, SNRPA, CUL1, PSMD3
E2F targets CDCA3, SPC25, CDC20, PLK1, LMNB1, UBE2T, TACC3, TK1, TOP2A, DIAPH3, MKI67, HMMR, KPNA2, KIF2C, BUB1B,
BIRC5, POLA2, MTHFD2, RNASEH2A, AURKB, STMN1, DCK, SMC4, TFRC, RACGAP1, SPC24, HMGA1, CIT, PRDX4,
EED, DCLRE1B, E2F8, HELLS, BRCA1, ATAD2, ASF1B, MCM3, CCNB2, CSE1L, PAICS, NOLC1, TUBG1
G2M checkpoint CENPF,MKI67, EXO1, TOP2A, STIL, BUB1, PML,CCNA2, STMN1, KPNA2, TPX2, KIF15, POLA2,RAD54L,CCNF,CDC20,
NEK2, SMC4, LMNB1, SNRPD1, PRC1, POLQ,CDC25A,HMGA, TROAP,MCM3, E2F2,CDC7, BIRC5, TACC3,NUSAP1,
KIF11, E2F3, AURKB, TTK, HMMR, H2AFV, PBK, CENPA, KIF2C, PLK1, SQLE, NOLC1
Mitotic spindle KIF11, LMNB1, TPX2, CENPF, TOP2A, BCAR1, TTK, ANLN, KIF2C, BIRC5, NEK2, PRC1, SMC4, NUSAP1, MYO1E,
CD2AP, KIF15, KIFAP3, DOCK2, STAU1, KNTC1, FARP1, CCNB2
Unfolded protein response ALDH18A1, PAIP1, EXOC2, TATDN2, VEGFA, PDIA6, IARS, WIPI1, HSP90B1, NOLC1, SSR1, XPOT
Interferon alpha response ADAR, CXCL10, ISG15, CD74, RSAD2, LGALS3BP, OAS1, RTP4, TRIM14, PARP12, IFIH1, EIF2AK2, IFI44, IFI44L, BST2,
OASL, SAMD9L, IFIT2, IFITM1, PSMB8, TDRD7, UBE2L6, PSME2, IFIT3, SP110
Interferon gamma response CXCL10, TDRD7, RSAD2, PARP12, SAMD9L, IFIT2, UBE2L6, OASL, IFIH1, TRIM14, CD74, IL15, BST2, IFIT3, ADAR,
CD8A, CD3E, CSK, CXCL13, HLA-DMA, CD2, STAT1, LTB, CD86, TIMP1, PRKCG, IFNG, IRF8, HLA-DOB
Allograft CXCR3, INHBA, IL12RB1, GPR65, CD74, CD3G, SOCS5, CD1D, GALNT1
Complement OLR1, GNGT2, FN1, MMP13, TFPI2, SERPINE1, DOCK10, C1QC, APOC1, COL4A2, MMP12
Angiogenesis OLR1, VAV2, POSTN, SPP1, LUM, VEGFA
Epithelial mesenchymal
translation
COL11A1, BGN, INHBA, EDIL3, TFPI2, CDH11, LOXL1, SPP1, PLOD2, PLOD1, TGM2, COL4A2, COL4A1, ITGB1, POSTN,
THBS1, ADAM12, RGS4, BASP1, FOXC2, FBN2, PPIB, VEGFA, LUM, TPM4, COMP, TNC
Glycolysis COL5A1, STMN1, PLOD2, CXCR4, PLOD1, DSC2, CHST1, VEGFA, HS6ST2, FUT8, P4HA2, HS2ST1, PSMC4, CHST6,
PDK3, P4HA1, CLDN3, TSTA3, CLN6
Estrogen early response KLF4, SEMA3B, HSPB8, ABLIM1, WISP2, FOS, CYP26B1, LRIG1, CXCL12, DLC1, FKBP5, KLK10
Estrogen late response SCUBE2, KLF4, SEMA3B, HSPB8, WISP2, FOS, CYP26B1, RABEP1, HMGCS2, CXCL12, FKBP5, TNNC1, KLK10, CAV1
Fatty acid metabolism ACSM3, HMGCS2, ADIPOR2, CA4, SLC22A5, MGLL, CD36, CIDEA
Adipogenesis HSPB8, MGLL, ITIH5, CD36, CIDEA, FABP4, SAMM50, SORBS1, ADIPOR2, DHRS7, ENPP2, FZD4, ACAA2, ACADM
6
RESEARCH ARTICLE Disease Models & Mechanisms (2019) 12, dmm040444. doi:10.1242/dmm.040444
D
is
ea
se
M
o
d
el
s
&
M
ec
h
an
is
m
s
significantly deregulated in both species include interferon alpha and
gamma responses, allograft rejection and complement. Here,
CXCL10, its receptor CXCR3, and CD74 were detected in most
immune-related pathways in both human and canine CAS. The
chemokine interferon gamma inducible protein CXCL10 is a
member of the CXCR3 chemokine family that interconnects with
various signalling pathways. In breast cancer, Ras-induced CXCL10
overexpression contributes to the development of breast tumours
(Parl et al., 1984), and overexpression of CXCR3 is associated with
poorer overall survival (Bronger et al., 2017). Expression of CD74, a
chaperone protein with an important role in innate immunity, in
breast cancer tissue is correlated with increased metastasis
(Metodieva et al., 2013; Nieto et al., 2000). We also found
hormone-related pathways, such as estrogen response, enriched in
both human and canine CAS. In humans, benign tumours are likely
to be estrogen receptor (ER)-positive with a better prognosis
(Maynard et al., 1978), whereas ER-negative tumours are more
likely to be of higher histological grade (Parl et al., 1984; Putti et al.,
2004). The effect of ER expression on prognosis of canine mCA
remains unclear (De las Mulas et al., 2005; Nieto et al., 2000).
Likewise, the hormonal classification as a predictive marker of
favourable response to endocrine therapy has not been established in
canine mammary tumours, therefore, expression of hormone
receptors analysis is currently not routinely assessed in canine
mCA. Other common pathways include fatty acid metabolism,
MTORC1 signalling, MYC targets v1, E2F targets, G2M
checkpoint, mitotic spindle and unfolded protein response
(Corazzari et al., 2017; Jardé et al., 2008; Lan et al., 2018; Pease
and Tirnauer, 2011; Poole and van Riggelen, 2017; Silvera et al.,
2017; Wang et al., 2009).
Finally, we establish the prognostic potential of the canine CAS
signature in human samples (Fig. 4). These analyses strongly
support the notion that CAS from canine and human mCA are
highly comparable on a molecular level, suggesting similar
reprogramming mechanisms underlying the development of CAS
in human and canine mCA.
In conclusion, we provide a proof-of-principle to analyse specific
subsections of FFPE tissue isolated through LCM by RNAseq,
which unlocks a new dimension of difficult-to-analyse samples that
now become amenable to investigation. This first study to
systematically analyse gene expression in CAS and normal stroma
from canine mCA reveals detailed insights into the biology of CAS
in both canine tumour types and their comparability with the human
counterpart, which support the validity of spontaneous canine mCA
as a model to identify disease-promoting features with relevance to
the human disease.
MATERIALS AND METHODS
Ethics approval and consent to participate
No animals were killed for the purpose of this research project, as the tissue
analysed had been surgically removed in a curative setting with the verbal
consent of the patient owners. According to the Swiss Animal Welfare Law
Art. 3c, Abs. 4 the preparation of tissues in the context of agricultural
production, diagnostic or curative operations on the animal or for determining
Fig. 4. Human orthologues of genes derived from the canine CAS signature are enriched among highly prognostic genes in human mCA. (A) Breast
cancer meta z-scores of the human orthologues of canine-derived CAS genes obtained fromPRECOGdatabase (Gentles et al., 2015).Top: genes upregulated in
CAS are enriched for positive meta z-scores, associated with adverse prognosis. Bottom: genes upregulated in normal stroma are enriched for negative
meta z-scores, associated with favourable prognosis. Refer to Table S2 for the full list of meta z-scores. (B) Stromal signature of canine mCA shows strong
association with survival in human breast carcinomas. Survival meta z-scores were obtained from PRECOG database (Gentles et al., 2015). A positive z-score
indicates an adversely prognostic gene, whereas a negative z-score indicates a favourably prognostic gene. Data shown for 20 genes with strongest association
with survival. Refer to Table S2 for the full list of meta z-scores.
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the health status of animal populations is not considered an animal experiment
and, thus, does not require an animal experimentation license. All the FFPE
specimens used were obtained for diagnostic reasons and do therefore not
require a formal ethics approval, in full compliance with national guidelines.
Cases selection and tissue processing
Fifteen dog mammary carcinoma samples were obtained from the Institute
of Veterinary Pathology of the Vetsuisse Faculty Zürich (Table 1). All
samples were archival FFPE tissue samples either from the Small Animal
Hospital of Zurich or external cases sent in by veterinarians practicing in
Switzerland. Details regarding selection criteria are described in Ettlin et al.
(2017). Paraffin blocks were routinely kept at room temperature. Tissue
processing for LCM was performed as described in Amini et al. (2017). All
cases were reviewed by a veterinary pathologist. The criteria for carcinoma
case selection were: female dogs, simple type of mCA, appropriate tumour
stroma content and areas with no obvious or only negligible inflammation.
Table 1 provides clinical details, such as age and breed of each patient,
sample age and tumour subtype, for all cases included in the study.
Laser-capture microdissection
LCM was used for selective isolation of matched CAS and normal
stroma from 15 canine simple mCA. LCM was performed using the
ArcturusXT™ Laser Capture Microdissection System (Thermo
Fisher Scientific) and Arcturus® CapSure® Macro LCM Caps (Life
Technologies) as described previously (Amini et al., 2017; Ettlin et al.,
2017). Areas for dissection were reviewed by a veterinary pathologist.
Highly enriched populations of normal or tumour-associated stroma from
the specimens were identified and isolated according to the manufacturer’s
protocol. Normal stroma samples were isolated from the same slides, from
regions specified by a pathologist that presented no obvious alterations and
were at least 2-4 mm away from the tumour, in accordancewith established
procedures (Finak et al., 2008). Isolation of cells of interest was verified by
microscopic examination of the LCM cap as well as the excised region
after microdissection (Fig. S1).
RNA isolation
RNA was isolated using the Covaris® truXTRAC FFPE RNA kit and the
Covaris® E220 focused ultrasonicator as described in Amini et al. (2017).
An overview of concentration, total yield and DV200 for all samples can be
found in Table S5.
Quantitative RT-PCR
Quantitative RT-PCR using Taqman® primers was performed as described
in Amini et al. (2017). Primers are detailed in Table S3.
Immunofluorescence
FFPE tissue sections (2 µm thickness) were mounted on positively
charged slides and dried overnight at 37°C. Drying was followed by the
deparaffinisation of the slides with four xylene baths for 5 min each using
the Tissue-Tek® Prisma® and Film® (Sysmex). For rehydration, a degressive
alcohol series using 100% ethanol, 95% ethanol, 70% ethanol and distilled
water was performed.
All immunofluorescence sections were counterstained with 0.1 mg/ml
DAPI (Thermo Fisher Scientific) at room temperature for 15 min to
visualise nuclei. Antibodies and conditions used for immunofluorescence
are detailed in Table S4.
RNA-seq library preparation
RNAseq was carried out on 4 ng of RNA from elution 1 (E1) diluted to a
concentration of 0.33 ng/μl in a total volume of 30 μl. The SMARTer
Stranded Total RNAseq Kit-Pico Input Mammalian (Clontech/Takara Bio
USA) was used according to manufacturer’s protocol for RNA library
preparation and ribosomal RNA depletion. Single-read sequencing
(125 bp) was obtained using the Illumina HiSeq 4000 according to
standard protocols of the Functional Genomics Centre Zurich. See Fig. S5
for a barplot of library sizes demonstrating the number of quantified reads
per sample.
Bioinformatics analyses
RNA-seq quantification was performed using kallisto 0.44.0 with sequence-
based bias correction using transcript sequences obtained from
ENSEMBLE (CanFam3.1) (Bray et al., 2016). All other parameters were
set to default when running kallisto. Kallisto’s transcript-level estimates
were further summarised at the gene-level using tximport 1.8.0 from
Bioconductor (Soneson et al., 2015). Both raw data and gene-by-sample
matrix of estimated counts were deposited online. For downstream analysis,
lowly abundant genes were filtered out and unwanted variation was
estimated using SVA 3.30.1 from Bioconductor (Leek et al., 2019).
Differential expression analysis was performed using DESeq2 1.22.0 from
Bioconductor (Love et al., 2014), with estimated factors of unwanted
variation included as additional covariates in the design formula. Significant
genes were identified using FDR and fold-change thresholds as indicated
per dataset. Heatmaps were generated using the pheatmap R Package
(Kolde, 2019), with clustering distance and method set to Euclidean and
ward.D2, respectively. Over-representation analysis of differentially
expressed genes was performed using the MSigDB webtool (http://
software.broadinstitute.org/gsea). GSEA was performed using fgsea 1.8.0
from Bioconductor (Sergushichev, 2016), with signal-to-noise ratio as
defined by Subramanian et al. (2005) as gene-level statistic. Before
performing GSEA, dog genes were converted to human orthologues using
biomaRt 2.38.0 from Bioconductor (Durinck et al., 2009). If a human
orthologue was associated with more than one dog gene, the dog gene with
maximum variance was selected using the collapseRows functionality within
the WGCNA R package (Miller et al., 2011). Signalling pathways analysed
by GSEA were obtained from the Hallmark gene sets of the MSigDB
(Liberzon et al., 2015). Processed microarray data was obtained from Gene
Expression Omnibus under accession number GSE35019. The barcode
enrichment plot was generated using the barcodeplot functionality, and
significance was assessed using the geneSetTest functionality, both within
limma 3.38.3 from Bioconductor (Ritchie et al., 2015). The human stromal
gene signature was obtained from the ESTIMATE R package (Yoshihara
et al., 2013). TCGA processed data was obtained from cbioportal data portal
(Gao et al., 2013), and the enrichment of canine and human stromal signatures
in TCGA’s BRCA data was computed using ssgsea functionality within
GSVA 1.30.0 fromBioconductor (Hänzelmann et al., 2013). Survival meta z-
scores were obtained from PRECOG database (https://precog.stanford.edu,
Gentles et al., 2015). Enrichment of canine CAS signature among highly
prognostic genes was assessed using pre-ranked GSEA as implemented in
fgsea 1.8.0 fromBioconductor (Sergushichev, 2016), with PRECOG’s Breast
Cancer meta z-scores as gene-level statistic.
Acknowledgements
The authors thank the histology laboratory of the Institute of Veterinary Pathology,
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